INBIOGEN Co., Ltd. (KRX:101140)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,320.00
0.00 (0.00%)
At close: Aug 21, 2026

INBIOGEN Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-20,727-1,41916,12211,344-117,21894,125
Depreciation & Amortization
126.29363.491,0571,2241,4381,117
Loss (Gain) From Sale of Assets
-20.81-61.39168.1465.35-138.43
Asset Writedown & Restructuring Costs
1,0521,052992.37---
Loss (Gain) From Sale of Investments
-28.03-30.651.04-39,032178,976-123,863
Loss (Gain) on Equity Investments
16,708-2,979-21,53832,458-42,7775,062
Provision & Write-off of Bad Debts
35.2241.93146.46129.11-73.23361.64
Other Operating Activities
-20.69-18.8546.74-8,551-29,52718,627
Change in Accounts Receivable
-576.07-1,701-115.22,5831,718-2,088
Change in Inventory
34.8681.166.65-605.69-835.19-450.99
Change in Accounts Payable
46.85-422.67218.13-233.19-412.39-60.71
Change in Other Net Operating Assets
-267.22-461.642,301-432.25-2,794-37.39
Operating Cash Flow
-3,636-5,554-33.13-1,051-11,505-7,069
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-4.1-42.5-84.28-25.96-130.68-2,360
Sale of Property, Plant & Equipment
20.8364.9810.0573.8129.844.6
Sale (Purchase) of Intangibles
-46.11---305-200-41.15
Investment in Securities
---64.43-15,664-38,000
Other Investing Activities
-444000-
Investing Cash Flow
-29.37466.48-74.23-192.72-15,925-40,437

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-500---15,000
Total Debt Issued
3,500500---15,000
Long-Term Debt Repaid
--227.03-265.3-1,895-28,432-777.72
Total Debt Repaid
-234.06-227.03-265.3-1,895-28,432-777.72
Net Debt Issued (Repaid)
3,266272.97-265.3-1,895-28,43214,222
Issuance of Common Stock
----12,000-
Repurchase of Common Stock
----62.49--
Other Financing Activities
-0-0--0--0
Financing Cash Flow
3,266272.97-265.3-1,95713,56861,543

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Miscellaneous Cash Flow Adjustments
00-0-0--0
Net Cash Flow
-399.79-4,815-372.65-3,201-13,86214,038

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-3,640-5,597-117.41-1,077-11,636-9,430
Free Cash Flow Growth
------
Free Cash Flow Margin
-71.33%-88.88%-1.67%-17.25%-111.67%-89.97%
Free Cash Flow Per Share
---11.76-126.51-3209.03-3155.62
Levered Free Cash Flow
-3,177-4,061-1,145-1,660-16,530-8,817
Unlevered Free Cash Flow
-3,089-4,012-1,113-1,496-14,226-6,423

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
135.8773.450.0310.7142.04220.28
Cash Income Tax Paid
--0.39-0.26-11.31.41-13.53
Change in Working Capital
-761.58-2,5042,4711,312-2,324-2,637